Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
43.19
+1.19 (2.83%)
At close: Dec 19, 2025, 4:00 PM EST
42.33
-0.86 (-1.99%)
After-hours: Dec 19, 2025, 7:51 PM EST
KNSA Market Cap
KNSA has a market cap or net worth of $3.27 billion as of December 19, 2025. Its market cap has increased by 114.58% in one year.
Market Cap
3.27B
Enterprise Value
2.93B
1-Year Change
114.58%
Ranking
Category
Stock Price
$43.19
Market Cap Chart
Since May 24, 2018, KNSA's market cap has increased from $943.14M to $3.27B, an increase of 247.10%. That is a compound annual growth rate of 17.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 3.27B | 129.22% |
| Dec 31, 2024 | 1.43B | 15.76% |
| Dec 29, 2023 | 1.23B | 18.45% |
| Dec 30, 2022 | 1.04B | 28.46% |
| Dec 31, 2021 | 810.82M | -32.59% |
| Dec 31, 2020 | 1.20B | 98.17% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 24, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 946.31B |
| Johnson & Johnson | 501.88B |
| AbbVie | 393.81B |
| UnitedHealth Group | 297.24B |
| AstraZeneca | 281.41B |
| Novartis AG | 260.53B |
| Merck & Co. | 249.91B |
| Abbott Laboratories | 217.56B |